— Oregon State researchers who published the article "The Cost of Multiple Sclerosis Drugs in the U.S. and the Pharmaceutical Industry," which appeared in the April 24 issue of Neurology.
At Medicare is Simple, we look to educate and enable you to choose among Medicare plans to help find the policy that may best fit your needs. Get free quotes using our advanced quoting technology. HealthCare Reform is also a hot topic of interest to people of all ages, and we look to keep you updated on the issues relevant to learning more. Medicare Is Simple 800-442-4915
Wednesday, May 27, 2015
"A flourishing pharmaceutical industry
...provides
invaluable benefit to society by developing new drugs to combat disease and
alleviate suffering. The success of the pharmaceutical industry in bringing new
therapies to market for the treatment of MS has improved the care of people
with MS. However, the unbridled rise in the cost of MS drugs has resulted in
large profit margins and the creation of an industry 'too big to fail.' It is
time for neurologists to begin a national conversation about unsustainable and
suffocating drug costs for people with MS — otherwise we are failing our
patients and society."
— Oregon State researchers who published the article "The Cost of Multiple Sclerosis Drugs in the U.S. and the Pharmaceutical Industry," which appeared in the April 24 issue of Neurology.
— Oregon State researchers who published the article "The Cost of Multiple Sclerosis Drugs in the U.S. and the Pharmaceutical Industry," which appeared in the April 24 issue of Neurology.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment